<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10197731" created="16/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10197731</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Studies into the effect of <term id="T1" lex="tyrosine_phosphatase_inhibitor" sem="Organic_compound_other"><term id="T2" lex="tyrosine_phosphatase" sem="Protein_family_or_group"><term id="T3" lex="tyrosine" sem="Amino_acid_monomer">tyrosine</term> phosphatase</term> inhibitor</term> <term id="T4" lex="phenylarsine_oxide" sem="Organic_compound_other">phenylarsine oxide</term> on <term id="T5" lex="NFkappaB_activation" sem="Other"><term id="T6" lex="NFkappaB" sem="Protein_complex">NFkappaB</term> activation</term> in <term id="T7" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> during aging: evidence for altered <cons id="C1" lex="(AND IkappaB-alpha_phosphorylation IkappaB-alpha_degradation)" sem="(AND Other Other)"><frag id="F7">IkappaB-alpha</frag> <frag id="F8">phosphorylation</frag> and <frag id="F9">degradation</frag></cons>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<clue>Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB <clueType>activation</clueType> in T lymphocytes during aging: evidence for altered IkappaB-alpha phosphorylation and degradation.</clue>
</event>
<event KT="Investigation" id="E2" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E1"/>
<cause idref="T4"/>
<clue><clueKT>Studies</clueKT> into the <clueType>effect</clueType> <linkCause>of</linkCause> tyrosine phosphatase inhibitor phenylarsine oxide <linkTheme>on</linkTheme> NFkappaB activation <clueLoc>in T lymphocytes</clueLoc> <clueTime>during aging</clueTime>: evidence for altered IkappaB-alpha phosphorylation and degradation.</clue>
</event>
<event KT="Other" id="E3">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="F7"/>
<clue>Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: evidence for altered IkappaB-alpha <clueType>phosphorylation</clueType> and degradation.</clue>
</event>
<event KT="Other" id="E4">
<type class="Protein_catabolism"/>
<theme idref="F7"/>
<clue>Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: evidence for altered IkappaB-alpha phosphorylation and <clueType>degradation</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E5">
<type class="Regulation"/>
<theme idref="E3"/>
<clue>Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: <clueKT><clueCL>evidence</clueCL></clueKT> for <clueType>altered</clueType> IkappaB-alpha phosphorylation and degradation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E6">
<type class="Regulation"/>
<theme idref="E4"/>
<clue>Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB activation in T lymphocytes during aging: <clueKT><clueCL>evidence</clueCL></clueKT> for <clueType>altered</clueType> IkappaB-alpha phosphorylation and degradation.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T10" lex="nuclear_Factor_kappa_B" sem="Protein_complex">Nuclear Factor kappa B</term> (<term id="T11" lex="NFkappaB" sem="Protein_complex">NFkappaB</term>) is a critical regulator of several <term id="A1" sem="DNA_domain_or_region">genes</term> involved in <cons id="T12" lex="(AND immune_response inflammatory_response)" sem="(AND Other Other)"><frag id="F1">immune</frag> and <frag id="F2">inflammatory</frag> <frag id="F3">responses</frag></cons>.</sentence>
<event KT="Other" id="E7">
<type class="Correlation"/>
<theme idref="A1"/>
<theme idref="F1" idref1="F3"/>
<clue>Nuclear Factor kappa B (NFkappaB) is a critical regulator of several genes <clueType>involved</clueType> <linkTheme>in</linkTheme> immune and inflammatory responses.</clue>
</event>
<event KT="Other" id="E8">
<type class="Correlation"/>
<theme idref="A1"/>
<theme idref="F2" idref1="F3"/>
<clue>Nuclear Factor kappa B (NFkappaB) is a critical regulator of several genes <clueType>involved</clueType> <linkTheme>in</linkTheme> immune and inflammatory responses.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Regulation"/>
<theme idref="A1"/>
<cause idref="T11"/>
<clue>Nuclear Factor kappa B (NFkappaB) is a critical <clueType>regulator</clueType> <linkTheme>of</linkTheme> several genes involved in immune and inflammatory responses.</clue>
</event>
<sentence id="S3">Treatment of <term id="T13" lex="T_cell" sem="Cell_natural">T cells</term> with a variety of stimuli, including <term id="T14" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>, leads to the translocation of the active <term id="T15" lex="p65-50_heterodimer" sem="Protein_complex">p65-50 heterodimer</term> to the <term id="T16" lex="nucleus" sem="Cell_component">nucleus</term>, albeit at a lower level in <term id="T17" lex="T_cell" sem="Cell_natural">T cells</term> from the elderly.</sentence>
<event KT="Method" id="E10">
<type class="Artificial_process"/>
<theme idref="T13"/>
<theme idref="T14"/>
<clue><clueType>Treatment</clueType> <linkTheme>of</linkTheme> T cells <linkTheme>with</linkTheme> <corefTheme>a variety of stimuli</corefTheme>, including TNF-alpha, leads to the translocation of the active p65-50 heterodimer to the nucleus, albeit at a lower level in T cells from the elderly.</clue>
</event>
<event KT="Other" id="E11">
<type class="Localization"/>
<theme idref="T15"/>
<clue>Treatment of T cells with a variety of stimuli, including TNF-alpha, leads to the <clueType>translocation</clueType> <linkTheme>of</linkTheme> the active p65-50 heterodimer <clueLoc>to the nucleus</clueLoc>, albeit at a lower level in T cells from the elderly.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="E10"/>
<clue>Treatment of T cells with a variety of stimuli, including TNF-alpha, <clueType>leads</clueType> <linkTheme>to</linkTheme> the translocation of the active p65-50 heterodimer to the nucleus, albeit at a lower level in T cells from the elderly.</clue>
</event>
<sentence id="S4">We demonstrate here that pretreatment with <term id="T18" lex="PAO" sem="Organic_compound_other">PAO</term> results in the inhibition of <term id="T19" lex="NFkappaB_induction" sem="Other"><term id="T20" lex="NFkappaB" sem="Protein_complex">NFkappaB</term> induction</term> in <term id="T21" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term> treated <term id="T22" lex="T_cell" sem="Cell_natural">T cells</term>, suggesting a role for <term id="T23" lex="PAO-sensitive_phosphatase" sem="Protein_molecule"><term id="T24" lex="PAO" sem="Organic_compound_other">PAO</term>-sensitive phosphatase</term> in the activation of the <term id="T25" lex="NFkappaB" sem="Protein_complex">NFkappaB</term> via this pathway in <term id="T26" lex="human_T_cell" sem="Cell_natural">human T cells</term>.</sentence>
<event KT="Method" id="E13">
<type class="Artificial_process"/>
<theme idref="T18"/>
<clue>We demonstrate here that <clueType>pretreatment</clueType> <linkTheme>with</linkTheme> PAO results in the inhibition of NFkappaB induction in TNF-alpha treated T cells, suggesting a role for PAO-sensitive phosphatase in the activation of the NFkappaB via this pathway in human T cells.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="T20"/>
<clue>We demonstrate here that pretreatment with PAO results in the inhibition of NFkappaB <clueType>induction</clueType> in TNF-alpha treated T cells, suggesting a role for PAO-sensitive phosphatase in the activation of the NFkappaB via this pathway in human T cells.</clue>
</event>
<event KT="Other" id="E22">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<clue>We demonstrate here that pretreatment with PAO results in the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NFkappaB induction in TNF-alpha treated T cells, suggesting a role for PAO-sensitive phosphatase in the activation of the NFkappaB via this pathway in human T cells.</clue>
</event>
<event KT="Analysis" id="E15">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="E13"/>
<clue>We <clueKT>demonstrate</clueKT> here that pretreatment with PAO <clueType>results</clueType> <linkTheme>in</linkTheme> the inhibition of NFkappaB induction <clueLoc>in TNF-alpha treated T cells</clueLoc>, suggesting a role for PAO-sensitive phosphatase in the activation of the NFkappaB via this pathway in human T cells.</clue>
</event>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<clue>We demonstrate here that pretreatment with PAO results in the inhibition of NFkappaB induction in TNF-alpha treated T cells, suggesting a role for PAO-sensitive phosphatase in the <clueType>activation</clueType> <linkTheme>of</linkTheme> the NFkappaB via this pathway in human T cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E17" uncertainty="probable">
<type class="Correlation"/>
<theme idref="E16"/>
<theme idref="T23"/>
<clue>We demonstrate here that pretreatment with PAO results in the inhibition of NFkappaB induction in TNF-alpha treated T cells, <clueKT><clueCL>suggesting</clueCL></clueKT> a <clueType>role</clueType> <linkCause>for</linkCause> PAO-sensitive phosphatase <linkTheme>in</linkTheme> the activation of the NFkappaB via this pathway <clueLoc>in human T cells</clueLoc>.</clue>
</event>
<sentence id="S5">Furthermore, it demonstrates that <term id="A5" sem="Other">aging</term> does not influence the sensitivity of this <term id="T27" lex="phosphatase" sem="Protein_family_or_group">phosphatase</term>.</sentence>
<event KT="Other" id="E18">
<type/>
<cause idref="T23"/>
<clue>Furthermore, it demonstrates that aging does not influence the <clueType>sensitivity</clueType> <linkCause>of</linkCause> <corefCause>this phosphatase</corefCause>.</clue>
<comment>SENSITIVITY</comment></event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E19">
<type class="Regulation"/>
<theme idref="E18"/>
<cause idref="A5"/>
<clue>Furthermore, it <clueKT>demonstrates</clueKT> that aging does <cluePolarity>not</cluePolarity> <clueType>influence</clueType> the sensitivity of this phosphatase.</clue>
</event>
<sentence id="S6">Treatment with <term id="T28" lex="DMP" sem="Organic_compound_other">DMP</term> prior to treatment with <term id="T29" lex="PAO" sem="Organic_compound_other">PAO</term> and <term id="T30" lex="TNF" sem="Protein_family_or_group">TNF</term> abolishes the inhibition induced by <term id="T31" lex="PAO" sem="Organic_compound_other">PAO</term>, in <term id="T32" lex="T_cell" sem="Cell_natural">T cells</term> from both <cons id="T33" lex="(AND young_donor old_donor)" sem="(AND Multicellular_organism_natural Multicellular_organism_natural)"><frag id="F4">young</frag> and <frag id="F5">old</frag> <frag id="F6">donors</frag></cons>, alike.</sentence>
<event KT="Method" id="E20">
<type class="Artificial_process"/>
<theme idref="T28"/>
<clue><clueType>Treatment</clueType> <linkTheme>with</linkTheme> DMP prior to treatment with PAO and TNF abolishes the inhibition induced by PAO, in T cells from both young and old donors, alike.</clue>
</event>
<event KT="Method" id="E21">
<type class="Artificial_process"/>
<theme idref="T29"/>
<theme idref="T30"/>
<clue>Treatment with DMP prior to <clueType>treatment</clueType> <linkTheme>with</linkTheme> PAO and TNF abolishes the inhibition induced by PAO, in T cells from both young and old donors, alike.</clue>
</event>
<event KT="Other" id="E23">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T31"/>
<clue>Treatment with DMP prior to treatment with PAO and TNF abolishes the <corefTheme>inhibition</corefTheme> <clueType>induced</clueType> <linkCause>by</linkCause> PAO, in T cells from both young and old donors, alike.</clue>
</event>
<event id="E24">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E20"/>
<clue>Treatment with DMP prior to treatment with PAO and TNF <clueType>abolishes</clueType> the inhibition induced by PAO, <clueLoc>in T cells from</clueLoc> both <clueLoc>young</clueLoc> and old <clueLoc>donors</clueLoc>, alike.</clue>
</event>
<event id="E124">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E20"/>
<clue>Treatment with DMP prior to treatment with PAO and TNF <clueType>abolishes</clueType> the inhibition induced by PAO, <clueLoc>in T cells from</clueLoc> both young and <clueLoc>old donors</clueLoc>, alike.</clue>
</event>
<sentence id="S7">Finally, we demonstrate that a failure to degrade <term id="T34" lex="IkappaB-alpha" sem="Protein_molecule">IkappaB-alpha</term> in cytosols of <term id="T35" lex="TNF-treated_T_cell" sem="Cell_natural"><term id="T36" lex="TNF" sem="Protein_family_or_group">TNF</term>-treated <term id="T37" lex="T_cell" sem="Cell_natural">T cells</term></term> pretreated with <term id="T38" lex="PAO" sem="Organic_compound_other">PAO</term> is due to its interference with the <term id="T39" lex="phosphorylation" sem="Other">phosphorylation</term> of <term id="T40" lex="IkappaB-alpha" sem="Protein_molecule">IkappaB-alpha</term> and not due to its inhibitory effect on <term id="T41" lex="proteasomal_degradation" sem="Other">proteasomal degradation</term>.</sentence>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E25">
<type class="Protein_catabolism"/>
<theme idref="T34"/>
<clue>Finally, we demonstrate that a <cluePolarity>failure</cluePolarity> to <clueType>degrade</clueType> IkappaB-alpha <clueLoc>in cytosols of TNF-treated T cells pretreated with PAO</clueLoc> is due to its interference with the phosphorylation of IkappaB-alpha and not due to its inhibitory effect on proteasomal degradation.</clue>
</event>
<event KT="Other" id="E26">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T40"/>
<clue>Finally, we demonstrate that a failure to degrade IkappaB-alpha in cytosols of TNF-treated T cells pretreated with PAO is due to its interference with the <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> IkappaB-alpha and not due to its inhibitory effect on proteasomal degradation.</clue>
</event>
<event KT="Other" id="E27">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="T38"/>
<clue>Finally, we demonstrate that a failure to degrade IkappaB-alpha in cytosols of TNF-treated T cells pretreated with PAO is due to <corefCause>its</corefCause> <clueType>interference</clueType> <linkTheme>with</linkTheme> the phosphorylation of IkappaB-alpha and not due to its inhibitory effect on proteasomal degradation.</clue>
</event>
<event KT="Analysis" id="E28">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="E27"/>
<clue>Finally, we <clueKT>demonstrate</clueKT> that a failure to degrade IkappaB-alpha in cytosols of TNF-treated T cells pretreated with PAO is <clueType>due</clueType> <linkCause>to</linkCause> its interference with the phosphorylation of IkappaB-alpha and not due to its inhibitory effect on proteasomal degradation.</clue>
</event>
<event KT="Other" id="E29">
<type class="Negative_regulation"/>
<theme idref="T41"/>
<cause idref="T38"/>
<clue>Finally, we demonstrate that a failure to degrade IkappaB-alpha in cytosols of TNF-treated T cells pretreated with PAO is due to its interference with the phosphorylation of IkappaB-alpha and not due to <corefCause>its</corefCause> <clueType>inhibitory effect</clueType> <linkTheme>on</linkTheme> proteasomal degradation.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E30">
<type class="Regulation"/>
<theme idref="E25"/>
<cause idref="E29"/>
<clue>Finally, we <clueKT>demonstrate</clueKT> that a failure to degrade IkappaB-alpha in cytosols of TNF-treated T cells pretreated with PAO is due to its interference with the phosphorylation of IkappaB-alpha and <cluePolarity>not</cluePolarity> <clueType>due</clueType> <linkCause>to</linkCause> its inhibitory effect on proteasomal degradation.</clue>
</event>
<sentence id="S8">These data collectively suggest that <term id="T42" lex="PAO" sem="Organic_compound_other">PAO</term> interferes with the phosphorylation and the <term id="T43" lex="regulated_degradation" sem="Other">regulated degradation</term> of <term id="T44" lex="IkappaB-alpha" sem="Protein_molecule">IkappaB-alpha</term>, induced by <term id="T45" lex="TNF" sem="Protein_family_or_group">TNF</term>, without affecting the <term id="T46" lex="chymotryptic_activity" sem="Other">chymotryptic activity</term> of the <term id="T47" lex="proteasome" sem="Protein_complex">proteasome</term>, independent of <term id="A6" sem="Other">age</term>.</sentence>
<event KT="Other" id="E31">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T44"/>
<clue>These data collectively suggest that PAO interferes with the <clueType>phosphorylation</clueType> and the regulated degradation <linkTheme>of</linkTheme> IkappaB-alpha, induced by TNF, without affecting the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
<event KT="Other" id="E32">
<type class="Protein_catabolism"/>
<theme idref="T44"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated <clueType>degradation</clueType> <linkTheme>of</linkTheme> IkappaB-alpha, induced by TNF, without affecting the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
<event KT="Other" id="E33">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="T45"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, <clueType>induced</clueType> <linkCause>by</linkCause> TNF, without affecting the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="T45"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, <clueType>induced</clueType> <linkCause>by</linkCause> TNF, without affecting the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
<event CL="L2" KT="Analysis" id="E35">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T42"/>
<clue>These data collectively <clueKT><clueCL>suggest</clueCL></clueKT> that PAO <clueType>interferes</clueType> <linkTheme>with</linkTheme> the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, without affecting the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
<event CL="L2" KT="Analysis" id="E36">
<type class="Negative_regulation"/>
<theme idref="E34"/>
<cause idref="T42"/>
<clue>These data collectively <clueKT><clueCL>suggest</clueCL></clueKT> that PAO <clueType>interferes</clueType> <linkTheme>with</linkTheme> the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, without affecting the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
<event KT="Other" id="E37">
<type class="Positive_regulation"/>
<cause idref="T47"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, without affecting the <clueType>chymotryptic activity</clueType> <linkCause>of</linkCause> the proteasome, independent of age.</clue>
<comment>NO THEME</comment></event>
<event KT="Other" id="E38">
<type class="Regulation"/>
<theme idref="E37"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, without <clueType>affecting</clueType> the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E39" uncertainty="probable">
<type class="Correlation"/>
<theme idref="E35"/>
<theme idref="A6"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, without affecting the chymotryptic activity of the proteasome, <clueType><cluePolarity>independent</cluePolarity></clueType> <linkTheme>of</linkTheme> age.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E40" uncertainty="probable">
<type class="Correlation"/>
<theme idref="E36"/>
<theme idref="A6"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, without affecting the chymotryptic activity of the proteasome, <clueType><cluePolarity>independent</cluePolarity></clueType> <linkTheme>of</linkTheme> age.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E41" uncertainty="probable">
<type class="Correlation"/>
<theme idref="E35"/>
<theme idref="E38"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, <clueType><cluePolarity>without</cluePolarity></clueType> affecting the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E42" uncertainty="probable">
<type class="Correlation"/>
<theme idref="E36"/>
<theme idref="E38"/>
<clue>These data collectively suggest that PAO interferes with the phosphorylation and the regulated degradation of IkappaB-alpha, induced by TNF, <clueType><cluePolarity>without</cluePolarity></clueType> affecting the chymotryptic activity of the proteasome, independent of age.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
